Undergraduates, graduate students, medical students, and postdoctoral fellows are invited to learn about training opportunities available in the NIMH Intramural Research Program.
Source: nimh

An NIMH-funded research consortium has produced the largest and most advanced multidimensional maps of gene regulation networks in the brains of people with and without mental disorders.
Source: nimh

NIMH-supported research captures expressions of irritability across developmental stages via a clinically relevant measurement tool: the MAPS Temper Loss Scale.
Source: nimh

Decades of NIMH-supported basic research led to a pioneering treatment for postpartum depression and continues to power exciting advances in women's mental health care.
Source: nimh

Psychosis, a condition marked by a loss of touch with reality, is distressing for those who experience it and their loved ones. If left untreated, psychosis can have serious impacts on people's lives. But the good news is there's hope. In this episode, we talk with Dr. Robert Heinssen, a leader in the development and adoption of coordinated specialty care for treating psychosis. We learn about the signs and symptoms of psychosis, discuss coordinated specialty care, and explore how NIMH research in psychosis and schizophrenia fundamentally changed the health care landscape.
Source: nimh

NIMH leadership and staff will present several sessions featuring some of the major initiatives NIMH has undertaken or been involved with over the years.
Source: nimh

This workshop will convene researchers and federal officials to review the state of the science for neurofeedback intervention development for mental disorders, with an emphasis on real time fMRI approaches.
Source: nimh

NIMH expert Sarah H. Lisanby, M.D. will describe common types of brain stimulation therapies, and why they are used, dispel misconceptions, and highlight NIMH-supported research in this area.
Source: nimh

In this NIMH-supported study, researchers investigated the neural underpinnings of sensory hypersensitivity in SCN2A-associated autism.
Source: nimh

In a proof-of-concept study, researchers demonstrated the effectiveness of a potential new therapy for Timothy syndrome, an often life-threatening and rare genetic disorder that affects a wide range of bodily systems, leading to severe cardiac, neurological, and psychiatric symptoms as well as physical differences such as webbed fingers and toes.
Source: nimh